Beyond Air (XAIR) Company Report

Beyond Air reported Q2 2026 revenue of $1.8 million, a 128% increase year-over-year, and a net loss of ($7.9) million or ($1.25) per share for the fiscal quarter ended September 30, 2025.
The company updated its fiscal year 2026 revenue guidance to $8 - $10 million.
Beyond Air secured $12.0 million in debt financing, resulting in proforma cash, cash equivalents, restricted cash, and marketable securities of $22.9 million as of September 30, 2025. Bob Goodman was also appointed Interim Chief Commercial Officer.

Nov 14, 2025, 9:30 PM

Beyond Air Announces Q2 Fiscal Year 2026 Results and Updates Guidance

XAIR

Earnings

Guidance Update

Debt Issuance

Beyond Air reported Q2 fiscal year 2026 revenue of $1.8 million for the period ended September 30, 2025, representing a 128% increase year-over-year from $0.8 million in the same period last year, though sequential growth was flat.
The company updated its fiscal year 2026 revenue guidance to $8-$10 million.
Beyond Air secured $12 million in debt and plans to file a registration statement for an additional $20 million equity line of credit with Streeterville Capital, which is expected to provide financial runway into calendar 2027.
Operational highlights include the first international commercial placement of LungFit PH, the introduction of a capital purchase sales model in the U.S., and the appointment of Bob Goodman as interim Chief Commercial Officer.
The second-generation LungFit system is anticipated for commercial launch in the U.S. market in late calendar year 2026, pending FDA approval.

Nov 10, 2025, 9:30 PM

Beyond Air Secures $32 Million in Financing and Reprices Stock Options

XAIR

Debt Issuance

New Projects/Investments

Executive Compensation

Beyond Air, Inc. entered into financing agreements with Streeterville Capital for up to $32 million in total potential proceeds.
This financing package includes a $12 million promissory note with a 15% annual interest rate and a 24-month maturity, and a $20 million Equity Line of Credit (ELOC) for selling common stock over a 24-month period.
The company expects this financing to extend its cash runway into calendar 2027.
On November 4, 2025, Beyond Air approved a one-time stock option repricing for 726,618 options, adjusting the exercise price to $1.95 for options previously above this amount.